A 15-year overview of management and prognosis in primary fallopian tube carcinoma

European Journal of Cancer

Volumn 34, Issue 11, 1998, Pages 1725-1729

  Rosen, A C ^a   Ausch, Ch ^a   Hafner, E ^a   Klein, M ^b   Lahousen, M ^a   Graf, A H ^c   Reiner, A ^a  

^a SMZ Ost Vienna ^*

^b HANUSCH HOSPITAL   (Austria)

^c St Johanns Spital   (Austria)

Author keywords

Postoperative therapy; Primary fallopian tube carcinoma; Prognostic factors

Indexed keywords

CISPLATIN; PROTEIN P53;

ADULT; AGED; ARTICLE; ASCITES; CANCER STAGING; CANCER SURVIVAL; DNA DETERMINATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; UTERINE TUBE CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FALLOPIAN TUBE NEOPLASMS; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032190377     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00214-7     Document Type: Article

References (33)

1. 1. Hanton EM, Malkasian GD, Dahlin DC, Pratt J. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol 1966, 94, 832-839.
2. 2. Sedlis A. In Barber HRK, Graber EA, eds. Gynecological Oncology. Williams and Wilkins Co., 1969.
3. 3. Dodson MG, Ford JH, Averette HE. Clinical aspects of fallopian tube carcinoma. Obstet Gynecol 1970, 36, 935-939.
4. 4. Engeler V, Reinisch E, Schreiner WE. Das primä Tubenkarzinom - Eine klinische Studie an 37 Patientinnen. Geburtshilfe Frauenheikd 1981, 41, 325-329.
5. 5. Pfeiffer P, Mogensen H, Amtrup F, Honore E. Primary carcinoma of the fallopian tube. Acta Oncol 1989, 28, 7-11.
6. 6. Denham JW, MacLennan KA. The management of primary carcinoma of the fallopian tube: experiences with 40 patients. Cancer 1984, 53, 166-172.
7. 7. McMurray EH, Jacobs AJ, Perez CA, Camel HM, Kao MS, Galakatos A. Carcinoma of the fallopian tube. Cancer 1986, 58, 2070-2075.
8. 8. Pakisch B, Poschauko J, Stückleschweiger G, et al. Die Behandlung des primären karzinomes der tuba fallopii. Geburtsh Frauenheilkd 1990, 50, 593-596.
9. 9. Morris M, Gershenson DM, Burke ThW, Kavanagh JJ, Silva EG, Wharton T. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin and cyclophosphamide. Obstet Gynecol 1990, 76, 1020-1023.
10. 10. Cormio G, Maneo A, Gabriele A, Zanetta G, Losa G, Lissoni A. A treatment of fallopian tube carcinoma with cyclophosphamide, adriamycin and criplatin. Am J Clin Oncol 1997, 20, 143-145.
11. 11. Higgins RV, Meyers VT, Hall JB. Radiation myelopathy after chemotherapy and radiation therapy for fallopian tube carcinoma. Gynecol Oncol 1997, 64, 285-287.
12. 12. Pectasides D, Barbounis V, Sintila A, Varthalitis I, Dimitriadis M, Athanassiou A. Treatment of primary fallopian tube carcinoma with criplatin-containing chemotherapy. Am J Clin Oncol 1994, 17, 68-71.
13. 13. DiSaia PhJ, Creasman WT. Carcinoma of the fallopian tube. In Achenbach F, ed. Clinical Gynecology Oncology. St Louis, Mosby, 1997, 375-381.
14. 14. Hu CY, Taymor ML, Hertig AT. Carcinoma of the fallopian tube. Am J Obstet Gynecol 1950, 59, 58-67.
15. 15. Rosen AC, Graf AH, Klein M, et al. DNA ploidy in primary fallopian tube carcinoma using image cytometry. Int J Cancer 1994, 58, 362-365.
16. 16. Bartek J, Bartkova J, Vojtesek B, et al. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 1991, 6(9), 1699-1703.
17. 17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53, 457-481.
18. 18. Mantel N. Evaluation of survival data and two new rank order statistics arising in its considerations. Cancer Chemother Rep 1986, 50, 163-170.
19. 19. Cox DR. Regression models and life tables. J R Stat Soc B 1972, 34, 187-220.
20. 20. Pfleiderer A, Malignom der Tube. In Wulf K, Schmidt-Matthiesen H, eds. Klinik der Frauenheilkunde und Geburtshilfe, Bd.XII, Spezielle gynäkologische Onkologie II. München, Urban and Schwarzenberg, 1989, 38-44.
21. 21. Böhme M, Donat H, Baumann D. Das primäre Tubenkarzinom. Zentbl Gynäkol 1992, 114, 244-248.
22. 22. Kubista E, Kupka ST. Klinische Problematik, Therapie und Prophlyaxe des primären Tubenkarzinomes. Geburtsh Frauenheilkd 1977, 37, 1044-1049.
23. 23. Jones OV. Primary carcinoma of the uterine tube. Obstet Gynecol 1965, 26, 122-129.
24. 24. Eddy GL, Copeland LJ, Gershenson DM, Atkinson EN, Wharton JT, Rutledge FN. Fallopian tube carcinoma. Obstet Gynecol 1984, 64, 546-552.
25. 25. Benedet JL, White W. Malignant tumours of fallopian tube. In Coppleson M, ed. Gynecologic Oncology. Melbourne, Churchill Livingstone, 1981, 621-629.
26. 26. Green TH, Scully RE. Tumour of the fallopian tube. Clin Obstet Gynecol 1962, 5, 886-906.
27. 27. Podratz KC, Edward PhD, Podczaski S, et al. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol 1986, 154, 1319-1326.
28. 28. Barakat RR, Rubin SC, Saigo PE. Second look laparatomy in carcinoma of the fallopian tube. Obstet Gynecol 1993, 82, 748.
29. 29. Rosen AC, Sevelda P, Klein M, et al. A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer. Br J Cancer 1994, 69, 577-579.
30. 30. Yoonessi N. Carcinoma of the fallopian tube. Obstet Gynecol Surv 1979, 34, 257.
31. 31. Tresukosol D, Kudelka AP, Edwards CL, Fromm GL, Rosario Mante RN, Kavanagh JJ. Primary fallopian tube adenocarcinoma: clinical complete response after salvage treatment with high-dose palitaxel. Gynecol Oncol 1995, 58, 258-261.
32. 32. Jereczek B, Jassem J, Kobierska A. Primary cancer of the fallopian tube. Acta Obstet Scand 1996, 75, 281-286.
33. 33. Klein M, Rosen A, Lahousen M, et al. Evaluation of adjuvant therapy after surgery for primary carcinoma of the fallopian tube. Arch Gynecol Obstet 1994, 255, 19-24.